ArticleTrials2023

Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.

Kathrine Kronberg Jakobsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.